: Circular RNAs (circRNAs) are emerging molecular players in leukemogenesis and promising therapeutic targets. In KMT2A::AFF1 (MLL::AF4)-rearranged leukemia, an aggressive disease compared with other pediatric B-cell precursor (BCP) acute lymphoblastic leukemia (ALL), data about circRNAs are limited. Here, we disclose the circRNA landscape of infant patients with KMT2A::AFF1 translocated BCP-ALL showing dysregulated, mostly ectopically expressed, circRNAs in leukemia cells. Most of these circRNAs, apart from circHIPK3 and circZNF609, previously associated with oncogenic behavior in ALL, are still uncharacterized. An in vitro loss-of-function screening identified an oncogenic role of circFKBP5, circKLHL2, circNR3C1, and circPAN3 in KMT2A::AFF1 ALL, whose silencing affected cell proliferation and apoptosis. Further study in an extended cohort disclosed a significantly correlated expression of these oncogenic circRNAs and their putative involvement in common regulatory networks. Moreover, it showed that circAFF1 upregulation occurs in a subset of cases with HOXA KMT2A::AFF1 ALL. Collectively, functional analyses and patient data reveal oncogenic circRNA upregulation as a relevant mechanism that sustains the malignant cell phenotype in KMT2A::AFF1 ALL.

Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion / Tretti Parenzan, Caterina; Molin, Anna Dal; Longo, Giorgia; Gaffo, Enrico; Buratin, Alessia; Cani, Alice; Boldrin, Elena; Serafin, Valentina; Guglielmelli, Paola; Vannucchi, Alessandro M; Cazzaniga, Giovanni; Biondi, Andrea; Locatelli, Franco; Meyer, Lueder H; Buldini, Barbara; Te Kronnie, Geertruij; Bresolin, Silvia; Bortoluzzi, Stefania. - In: BLOOD ADVANCES. - ISSN 2473-9529. - 8:5(2024), pp. 1305-1319. [10.1182/bloodadvances.2023011291]

Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion

Serafin, Valentina;
2024

Abstract

: Circular RNAs (circRNAs) are emerging molecular players in leukemogenesis and promising therapeutic targets. In KMT2A::AFF1 (MLL::AF4)-rearranged leukemia, an aggressive disease compared with other pediatric B-cell precursor (BCP) acute lymphoblastic leukemia (ALL), data about circRNAs are limited. Here, we disclose the circRNA landscape of infant patients with KMT2A::AFF1 translocated BCP-ALL showing dysregulated, mostly ectopically expressed, circRNAs in leukemia cells. Most of these circRNAs, apart from circHIPK3 and circZNF609, previously associated with oncogenic behavior in ALL, are still uncharacterized. An in vitro loss-of-function screening identified an oncogenic role of circFKBP5, circKLHL2, circNR3C1, and circPAN3 in KMT2A::AFF1 ALL, whose silencing affected cell proliferation and apoptosis. Further study in an extended cohort disclosed a significantly correlated expression of these oncogenic circRNAs and their putative involvement in common regulatory networks. Moreover, it showed that circAFF1 upregulation occurs in a subset of cases with HOXA KMT2A::AFF1 ALL. Collectively, functional analyses and patient data reveal oncogenic circRNA upregulation as a relevant mechanism that sustains the malignant cell phenotype in KMT2A::AFF1 ALL.
2024
8
5
1305
1319
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion / Tretti Parenzan, Caterina; Molin, Anna Dal; Longo, Giorgia; Gaffo, Enrico; Buratin, Alessia; Cani, Alice; Boldrin, Elena; Serafin, Valentina; Guglielmelli, Paola; Vannucchi, Alessandro M; Cazzaniga, Giovanni; Biondi, Andrea; Locatelli, Franco; Meyer, Lueder H; Buldini, Barbara; Te Kronnie, Geertruij; Bresolin, Silvia; Bortoluzzi, Stefania. - In: BLOOD ADVANCES. - ISSN 2473-9529. - 8:5(2024), pp. 1305-1319. [10.1182/bloodadvances.2023011291]
Tretti Parenzan, Caterina; Molin, Anna Dal; Longo, Giorgia; Gaffo, Enrico; Buratin, Alessia; Cani, Alice; Boldrin, Elena; Serafin, Valentina; Guglielmelli, Paola; Vannucchi, Alessandro M; Cazzaniga, Giovanni; Biondi, Andrea; Locatelli, Franco; Meyer, Lueder H; Buldini, Barbara; Te Kronnie, Geertruij; Bresolin, Silvia; Bortoluzzi, Stefania
File in questo prodotto:
File Dimensione Formato  
blooda_adv-2023-011291-main.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 2.42 MB
Formato Adobe PDF
2.42 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1334693
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact